The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...
In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of ...
At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, ...
In July 2015, Abbott agreed to buy Tendyne for $225 million upfront and secured an option to acquire Cephea. Abbott CEO ...
CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results